A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

NCT01059084 ·Status: WITHDRAWN ·Phase: NA

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

NCT00362297 ·Status: COMPLETED ·Phase: PHASE4

A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

NCT00005663 ·Status: UNKNOWN ·Phase: PHASE3

A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients

NCT00001038 ·Status: COMPLETED ·Phase: PHASE3

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons

NCT01026454 ·Status: COMPLETED ·Phase: PHASE4

A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons

NCT00161434 ·Status: COMPLETED ·Phase: PHASE4

Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

NCT01346475 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

NCT01658826 ·Status: TERMINATED ·Phase: PHASE2

A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

NCT00076232 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

NCT00371592 ·Status: COMPLETED ·Phase: PHASE2

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

NCT00860977 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

NCT00001115 ·Status: COMPLETED ·Phase: NA

Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

NCT00803543 ·Status: COMPLETED ·Phase: NA

Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?

NCT01176409 ·Status: COMPLETED ·Phase: PHASE3

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

NCT00378976 ·Status: COMPLETED ·Phase: PHASE3

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

NCT00001649 ·Status: COMPLETED ·Phase: PHASE3

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

NCT00465205 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

NCT00306787 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients

NCT00000953 ·Status: COMPLETED ·Phase: PHASE2

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

NCT00405821 ·Status: COMPLETED ·Phase: PHASE2

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir

NCT01689285 ·Status: COMPLETED ·Phase: PHASE1

A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster

NCT00900783 ·Status: COMPLETED ·Phase: PHASE2

VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

NCT00306293 ·Status: COMPLETED ·Phase: PHASE4

A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster

NCT02152800 ·Status: COMPLETED ·Phase: PHASE4

Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster

NCT00006131 ·Status: COMPLETED ·Phase: NA